Last data update: 24 January 2024 16:39 CET
Plasmid name: pSa::Mu18A1 (LMBP 8002)
New search | Print data sheet |
Price category: | Cat. 1 (cf. price list) |
Status: | GeneCorner non-core plasmid |
Depositor's sequence: | not available |
Sequence analysis results Genecorner: |
- |
Cloned DNA: |
- |
Promoter: | - |
Ribosome binding site: |
- |
Terminator: | - |
Selection marker: | Neomycin (neo; kanamycin (kan)) Chloramphenicol (cam) Streptomycin (Sm) Sulfonamide (Sul) |
Replicon: | - |
Host range: | Escherichia coli |
Parental clone: | - |
Further information: | The plasmid was constructed in vivo based on natural plasmids. The plasmid is meant for in vivo cloning. The plasmid belongs to the IncW incompatibility family. |
EMBL Accession number: | - |
Latest sequence update: | 18/03/2013 |
Authenticity test: | The plasmid still needs to be subjected to the authenticity test. |
Class: | Recombinant plasmid |
Type: | Plasmid |
History of deposit: | This plasmid was deposited by M. Mergeay(1) and A. Provoost(1). (1) SCK.CEN, Mol, Belgium |
Plasmid reference: | - |
Restricted distribution: | - BCCM MTA |
Distributed as: | H/P active culture or plasmid DNA |
Host for distribution: | Escherichia coli K12 N100 |
Host reference: | Gottesman and Yarmolinsky, J. Mol. Biol. 31 (1968), 487-505 [PMID: 5637199] [DOI: 10.1016/0022-2836(68)90423-3] |
Cultivation medium: | LB-Lennox + chloramphenicol (34 μg/ml) + kanamycin (50 μg/ml) + spectinomycin (150 μg/ml)* |
Cultivation temperature: | 37°C |
Biosafety level: | L1 |
Cultivation remark: | *: selection of transformants on chloramphenicol; subsequent cultivation of a single colony in liquid medium with kanamycin and streptomycin. |
Other culture collection numbers: | SCK CM0221 |
Refer in your Materials and Methods: |
pSa::Mu18A1 (LMBP 8002) is available at BCCM/GeneCorner. This plasmid was deposited by M. Mergeay and A. Provoost. |
Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.